Sign Out
Table of undesirable effects: The following undesirable effects have been observed during clinical trials and/or post-MA use of tianeptine and are classified as a function of their frequency: Very common (≥1/10); common (≥1/100, <1/10); uncommon (≥1/1,000, <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10,000), and not known (cannot be estimated from the available data). (See table.)
Click on icon to see table/diagram/imageReporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
View ADR Monitoring Form
